109 related articles for article (PubMed ID: 16912189)
1. Tip60 protein isoforms and altered function in skin and tumors that overexpress ornithine decarboxylase.
Hobbs CA; Wei G; DeFeo K; Paul B; Hayes CS; Gilmour SK
Cancer Res; 2006 Aug; 66(16):8116-22. PubMed ID: 16912189
[TBL] [Abstract][Full Text] [Related]
2. Polyamine-mediated regulation of protein acetylation in murine skin and tumors.
Wei G; Hobbs CA; Defeo K; Hayes CS; Gilmour SK
Mol Carcinog; 2007 Aug; 46(8):611-7. PubMed ID: 17570504
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of polyamine biosynthesis alters intrinsic histone acetyltransferase and deacetylase activities in murine skin and tumors.
Hobbs CA; Paul BA; Gilmour SK
Cancer Res; 2002 Jan; 62(1):67-74. PubMed ID: 11782361
[TBL] [Abstract][Full Text] [Related]
4. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis.
Feith DJ; Shantz LM; Pegg AE
Cancer Res; 2001 Aug; 61(16):6073-81. PubMed ID: 11507056
[TBL] [Abstract][Full Text] [Related]
5. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.
Smith MK; Trempus CS; Gilmour SK
Carcinogenesis; 1998 Aug; 19(8):1409-15. PubMed ID: 9744537
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation.
Shantz LM; Guo Y; Sawicki JA; Pegg AE; O'Brien TG
Carcinogenesis; 2002 Apr; 23(4):657-64. PubMed ID: 11960919
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.
Lan L; Trempus C; Gilmour SK
Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of polyamines alter chromatin in murine skin and tumors without global changes in nucleosome acetylation.
Hobbs CA; Paul BA; Gilmour SK
Exp Cell Res; 2003 Nov; 290(2):427-36. PubMed ID: 14568000
[TBL] [Abstract][Full Text] [Related]
9. Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression.
Guo Y; Zhao J; Sawicki J; Peralta Soler A; O'Brien TG
Mol Carcinog; 1999 Sep; 26(1):32-6. PubMed ID: 10487519
[TBL] [Abstract][Full Text] [Related]
10. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.
O'Brien TG; Megosh LC; Gilliard G; Soler AP
Cancer Res; 1997 Jul; 57(13):2630-7. PubMed ID: 9205069
[TBL] [Abstract][Full Text] [Related]
11. Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis.
Feith DJ; Bol DK; Carboni JM; Lynch MJ; Sass-Kuhn S; Shoop PL; Shantz LM
Cancer Res; 2005 Jan; 65(2):572-8. PubMed ID: 15695401
[TBL] [Abstract][Full Text] [Related]
12. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice.
Morikawa T; Wanibuchi H; Morimura K; Ogawa M; Fukushima S
Jpn J Cancer Res; 2000 Jun; 91(6):579-81. PubMed ID: 10874208
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
Verma AK
Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficiency for odc modifies mouse skin tumor susceptibility.
Guo Y; Cleveland JL; O'Brien TG
Cancer Res; 2005 Feb; 65(4):1146-9. PubMed ID: 15734996
[TBL] [Abstract][Full Text] [Related]
15. Role of ornithine decarboxylase in epidermal tumorigenesis.
Clifford A; Morgan D; Yuspa SH; Soler AP; Gilmour S
Cancer Res; 1995 Apr; 55(8):1680-6. PubMed ID: 7712475
[TBL] [Abstract][Full Text] [Related]
16. Studies of the mechanism by which increased spermidine/spermine N1-acetyltransferase activity increases susceptibility to skin carcinogenesis.
Wang X; Feith DJ; Welsh P; Coleman CS; Lopez C; Woster PM; O'Brien TG; Pegg AE
Carcinogenesis; 2007 Nov; 28(11):2404-11. PubMed ID: 17675337
[TBL] [Abstract][Full Text] [Related]
17. Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice.
Paul B; Hayes CS; Kim A; Athar M; Gilmour SK
Carcinogenesis; 2005 Jan; 26(1):119-24. PubMed ID: 15375010
[TBL] [Abstract][Full Text] [Related]
18. Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin.
Gilmour SK; Birchler M; Smith MK; Rayca K; Mostochuk J
Cell Growth Differ; 1999 Nov; 10(11):739-48. PubMed ID: 10593650
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
[TBL] [Abstract][Full Text] [Related]
20. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis.
Gilmour SK; Verma AK; Madara T; O'Brien TG
Cancer Res; 1987 Mar; 47(5):1221-5. PubMed ID: 3815331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
